About Limula
Limula is a company based in La Tour De Peilz (Switzerland) founded in 2020 by Luc Henry and Yann Pierson. Limula has raised $6.8 million across 4 funding rounds from investors including University of Oxford, Open-i and Life Extension Ventures. Limula offers products and services including Unified Manufacturing Platform and Cell Processing Unit. Limula operates in a competitive market with competitors including PBS Biotech, m2p-labs, Membio, Bionet Engineering and MicroBiopharm Japan, among others.
- Total Equity Funding$6.8M (USD)
in 4 rounds
- Latest Funding Round$6.8M (USD), Seed
May 2024
- InvestorsUniversity of Oxford
& 8 more
Products & Services of Limula
Limula offers a comprehensive portfolio of products and services, including Unified Manufacturing Platform and Cell Processing Unit.
Automated device combining bioreactor and centrifuge for therapy production
Modular system for scalable cell therapy development and processing
Funding Insights of Limula
Limula has successfully raised a total of $6.8M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $6.8 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.8M
- Total Rounds 4
- Last Round Seed — $6.8M
- First Round $108,123
(Feb 2022)
- Investors Count 9
All 4 funding rounds of Limula with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2024 | $6.8M | Seed | – | Life Extension Ventures | |
| Nov 2022 | – | Grant | – | – | |
| Oct 2022 | – | Seed | – | – | |
| Feb 2022 | $108,123 | Debt – Conventional | – | – |
9 investors in total: 9 institutional.
Investors in Limula
Limula has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Oxford, Open-i and Life Extension Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on tech sectors | – | lifex.vc | New York, United States | |
Venture capital firm focused on science and tech-driven startups | – | verve.vc | Berlin, Germany | |
Zühlke is recognized as a global transformation partner focused on engineering and innovation. | – | zuehlke.com | Switzerland | |
Health pioneers are supported through funding and innovation by Lichtsteiner Foundation. | – | lichtsteinerfoundation.org | Berne, Switzerland | |
Grants and loans are provided by FIT for innovative startups. | 1994 | fondation-fit.ch | Lausanne, Switzerland | |
Multiple courses and degrees across various streams are offered. | – | ox.ac.uk | Oxford, United Kingdom | |
Startup awards are provided to support Swiss entrepreneurs. | – | devigier.ch | Solothurn, Switzerland | |
Innovation conferences are organized and hosted in Switzerland. | 2006 | swiss-innovation.com | Gwatt, Switzerland | |
- | – | biopole.ch | - |
Investor details for Limula
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Limula
7 people are tracked at Limula (4 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Luc Henry | CEO & Co-Founder | Leadership |
Yann Pierson | Co-Founder | Leadership |
Thomas Eaton | COO and co-founder | Leadership |
Shady Gawad | Head of Research And Development | Leadership |
Omran El Rifaï | R&D Mechatronics Engineer | Team |
Léo Corsini | R&D Mechatronics Engineer | Team |
Sarah de la Mota | Business Development Specialist | Team |
Complete people profiles for Limula
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Limula
3 dated milestones of Limula across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Limula is founded.
- Funding First funding round of $108K.
- Funding Latest funding round, Seed, of $6.8M.
Competitors of Limula
Limula operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PBS Biotech, m2p-labs, Membio, Bionet Engineering and MicroBiopharm Japan, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pbsbiotech.com | 2006 | Camarillo, United States | $70.21M | – | Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies | |
| m2p-labs.com | 2005 | Baesweiler, Germany | – | 107 | Micro-bioreactors are provided for screening and bioprocess development. | |
| membio.ca | 2018 | Kitchener, Canada | $280,000 | – | Developer of single-use bioreactors for cell and gene therapies | |
| bionet.com | 1999 | Santiago Papasquiaro, Mexico | – | – | Manufactures bioreactors, TFF systems, and software for biopharma and agri-food applications. | |
| microbiopharm.com | 2011 | Tokyo, Japan | – | – | Contract research and discovery services are provided to biopharma firms. | |
| aucteq.com | 2018 | Mannheim, Germany | – | – | Single-use bioreactors for cell culturing processes are provided. | |
| hyalose.com | 2000 | Oklahoma, United States | – | – | Recombinant hyaluronic acid is manufactured in varying molecular sizes. | |
| atspiro.com | 2019 | Lyngby, Denmark | $172,879 | 5 | Developer of an automated single-use bioreactor for fermentation and cell cultivation of microbial cells |
Detailed competitors of Limula
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Limula
The website of Limula (limula.ch) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 38.2% vs previous month
Latest news on Limula
Complete news archive for Limula
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Limula
10 companies that operate in the same segment as Limula (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Limula
Limula was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Limula is headquartered in La Tour De Peilz, Switzerland. It is registered at La Tour De Peilz, Vaud, Switzerland.
Luc Henry is the current CEO of Limula. They have also founded this company.
Limula is a funded company, having raised a total of $6.8M across 4 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $108.12K, raised on Feb 2022.
Limula was founded in 2020 as a provider of modular solutions for on-demand and scaled manufacturing of cell therapies. Operations focus on a proprietary bioreactor platform that integrates multiple manufacturing steps into a single automated device, supported by end-to-end process analytics. The company operates in the biotechnology sector, with services centered on cell therapy production efficiency. Based in Switzerland, as indicated by its domain.
Limula's top competitors include PBS Biotech, m2p-labs and Membio.
Limula offers Unified Manufacturing Platform and Cell Processing Unit.
Limula has 9 investors. Key investors include University of Oxford, Open-i, Life Extension Ventures, Verve Ventures, and Zühlke.
Limula operates through Limula Sa.